Ruoxu Li , Yuhui Jia , Xin Yi , Lixin Wang , Qing Huang
{"title":"Evaluation of six GFR estimation equations in Chinese patients with chronic kidney disease","authors":"Ruoxu Li , Yuhui Jia , Xin Yi , Lixin Wang , Qing Huang","doi":"10.1016/j.cca.2025.120374","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Glomerular filtration rate (GFR) is recognized as the most reliable indicator of renal function and is usually estimated based on the serum creatinine equations. However, the reliability of these equations in specific regions needs to be properly quantified. We evaluated the applicability of the abbreviated MDRD equation (aGFR), the modified abbreviated MDRD equation (maGFR), the CKD-EPI creatinine equation (C-GFRcr), the CKD-EPI creatinine-cystatin C equation (C-GFRcr-cys), the EKFC creatinine equation (E-GFRcr), and the EKFC creatinine-cystatin C equation (E-GFRcr-cys) to chronic kidney disease (CKD) patients in Chongqing, China.</div></div><div><h3>Methods</h3><div>A total of 234 adult patients with CKD were selected for the study. Their sex, age, and etiology of CKD were recorded, and serum creatinine and cystatin C were measured and traceable to primary reference materials. The technetium 99 m-labeled diethylenetriamine pentaacetate (<sup>99m</sup>Tc-DTPA) renal scintigraphy was used as the reference method for GFR measurement. Six GFR estimation equations were analyzed in the overall analysis and across various stages of CKD to evaluate differences, absolute differences, bias, precision, and accuracy.</div></div><div><h3>Results</h3><div>In the validation dataset, the differences for maGFR were smaller compared to other equations, while those for C-GFRcr-cys and E-GFRcr-cys were larger. The bias for C-GFRcr-cys and E-GFRcr-cys was significantly higher than that of the other equations, although all six equations exhibited similar levels of precision. In CKD stages 1 through 3, the accuracy of C-GFRcr-cys and E-GFRcr-cys was significantly lower when compared to the other equations. Conversely, in CKD stages 4 and 5, maGFR and E-GFRcr-cys demonstrated significantly greater accuracy than the other equations. In CKD stage 1, maGFR misclassified only 5.21 % of patients, whereas C-GFRcr-cys and E-GFRcr-cys had significantly higher misclassification rates of 66.67 % and 68.75 %, respectively, compared to the other equations.</div></div><div><h3>Conclusions</h3><div>Overall, maGFR performed better than other equations and can be used as a confirmatory test in CKD patients in Chongqing, China.</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"575 ","pages":"Article 120374"},"PeriodicalIF":2.9000,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009898125002530","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Glomerular filtration rate (GFR) is recognized as the most reliable indicator of renal function and is usually estimated based on the serum creatinine equations. However, the reliability of these equations in specific regions needs to be properly quantified. We evaluated the applicability of the abbreviated MDRD equation (aGFR), the modified abbreviated MDRD equation (maGFR), the CKD-EPI creatinine equation (C-GFRcr), the CKD-EPI creatinine-cystatin C equation (C-GFRcr-cys), the EKFC creatinine equation (E-GFRcr), and the EKFC creatinine-cystatin C equation (E-GFRcr-cys) to chronic kidney disease (CKD) patients in Chongqing, China.
Methods
A total of 234 adult patients with CKD were selected for the study. Their sex, age, and etiology of CKD were recorded, and serum creatinine and cystatin C were measured and traceable to primary reference materials. The technetium 99 m-labeled diethylenetriamine pentaacetate (99mTc-DTPA) renal scintigraphy was used as the reference method for GFR measurement. Six GFR estimation equations were analyzed in the overall analysis and across various stages of CKD to evaluate differences, absolute differences, bias, precision, and accuracy.
Results
In the validation dataset, the differences for maGFR were smaller compared to other equations, while those for C-GFRcr-cys and E-GFRcr-cys were larger. The bias for C-GFRcr-cys and E-GFRcr-cys was significantly higher than that of the other equations, although all six equations exhibited similar levels of precision. In CKD stages 1 through 3, the accuracy of C-GFRcr-cys and E-GFRcr-cys was significantly lower when compared to the other equations. Conversely, in CKD stages 4 and 5, maGFR and E-GFRcr-cys demonstrated significantly greater accuracy than the other equations. In CKD stage 1, maGFR misclassified only 5.21 % of patients, whereas C-GFRcr-cys and E-GFRcr-cys had significantly higher misclassification rates of 66.67 % and 68.75 %, respectively, compared to the other equations.
Conclusions
Overall, maGFR performed better than other equations and can be used as a confirmatory test in CKD patients in Chongqing, China.
期刊介绍:
The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.
The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.